Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272868 · ClinicalTrials.gov registry record · Phase 1
Fecal Microbial Transplant in Pediatric Crohn's Disease
A Phase 1 study, sponsored by Seattle Children's Hospital.
- Terminated
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT02272868: Clinical Trial Phase 1 study, sponsored by Seattle Children's Hospital.
NCT02272868 is a Phase 1 study that was terminated before completion, run by Seattle Children's Hospital. The registered enrollment target is 7 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02272868, a Phase 1 study, was terminated before completion, sponsored by Seattle Children's Hospital.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a double blind placebo control trial of fecal microbial transplantation for active Crohn's disease in patients 12 to 21 years of age.
Primary Outcome
Clinical disease activity index in Crohn's disease
Interventions
- DRUG Normal Saline
- BIOLOGICAL Fecal Microbial transplant
- DRUG rifaximin+omeprazole+miralax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-10-01 |
| Phase | Phase 1 |
Why NCT02272868 stopped before completion
NCT02272868 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 3 interventions - of which Normal Saline is the first listed.
NCT02272868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02272868 about?
NCT02272868 is a clinical study titled "Fecal Microbial Transplant in Pediatric Crohn's Disease". This is a double blind placebo control trial of fecal microbial transplantation for active Crohn's disease in patients 12 to 21 years of age.
What is the current status of trial NCT02272868?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2015-01. Estimated completion is 2016-10-01.
What interventions are being tested in trial NCT02272868?
The interventions under investigation include: Normal Saline (DRUG), Fecal Microbial transplant (BIOLOGICAL), rifaximin+omeprazole+miralax (DRUG).
Who is sponsoring clinical trial NCT02272868?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02272868's enrollment target sits among peer trials
7 1972nd of 2000 higher than 27 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia